Defining the value of future research to identify the preferred treatment of meniscal tear in the presence of knee osteoarthritis Academic Article uri icon

Overview

MeSH Major

  • Knee Injuries
  • Osteoarthritis, Knee
  • Tibial Meniscus Injuries

abstract

  • We conclude that current cost-effectiveness evidence does not support unqualified rejection of either Immediate or Delayed APM for the treatment of MT+OA. The amount to which society would be willing to pay for additional information on treatment outcomes greatly exceeds the cost of conducting another randomized controlled trial on APM.

publication date

  • June 18, 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4472814

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0130256

PubMed ID

  • 26086246

Additional Document Info

start page

  • e0130256

volume

  • 10

number

  • 6